Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.209 USD | +1.33% | +2.26% | -68.53% |
06:44pm | TFF Pharmaceuticals, Leidos to Advance Biodefense Countermeasures Into Preclinical Testing | MT |
05-20 | TFF Pharmaceuticals Advances Influenza Vaccine Candidates Into Preclinical Testing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.53% | 6.75M | |
+64.15% | 62.59B | |
-1.22% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.19% | 26.21B | |
-21.87% | 19.09B | |
+4.99% | 13.08B | |
+25.26% | 12.26B | |
+28.61% | 12.05B |
- Stock Market
- Equities
- TFFP Stock
- News TFF Pharmaceuticals, Inc.
- TFF Pharmaceuticals : B. Riley Lowers TFF Pharmaceuticals' PT to $31 from $36 Driven by Research and Development Spend Growth, Keeps Buy Rating